Competent Cells Market Size, Share, Trends, Growth 2030

The global competent cells market size was evaluated at $2,230.56 million in 2022 and is slated to hit $5,012.16 million by the end of 2030 with a CAGR of nearly 10.65% between 2023 and 2030.

Request Free Sample

Key Insights:

• As per the analysis shared by our research analyst, the competent cells market is anticipated to grow at a CAGR of 10.65% during the forecast period (2023-2030).
• The global competent cells market was estimated to be worth approximately USD 2,230.56 million in 2022 and is projected to reach a value of USD 5,012.16 million by 2030.
• The growth of the competent cells market is being driven surging commercial demand for molecular clone solutions is one of the major factors driving the growth of the global competent cells market.
• Based on the type, the electro segment is growing at a high rate and is projected to dominate the market.
• On the basis of application, the protein expression segment is projected to swipe the largest market share.
• In terms of end user, the contract research organizations segment is expected to dominate the market.
• By region, North America is expected to dominate the global market during the forecast period.

Global Competent Cells Market: Overview

Competent cells are utilized in the transformation process. Transformation refers to the intake of extracellular DNA to modify the genes of particular cells. Transformation is a unique process in molecular cloning and associated biotechnological applications. Technology is vital in the development and innovation of vaccines for the treatment of several diseases. Furthermore, competent cells are a kind of bacterial cells that accept the plasmid and extrachromosomal DNA. E Coli possesses the property to inculcate foreign DNA into cells.

The cell wall is made with the help of heat shock and calcium chloride. The bacteria is then cooled down with the help of calcium chloride at zero degrees and later heated at 47 degrees for some time. The calcium chloride treatment is done to neutralize the action of phospholipid in the membrane. On other hand, the heat causes a thermal gradient that helps in making space for DNA to enter the competent cell. However, such cells are widely utilized for the transformation process.

Request Free Sample

Global Competent Cells Market: Growth Factors

The development in the field of molecular cloning research owing to the emergence of modern technology along with the surging commercial demand for molecular clone solutions is one of the major factors driving the growth of the global competent cells market.

The outbreak of the Covid-19 pandemic is positively impacting the growth of the market. The outbreak of pandemic has significantly scaled the research and development activities in the field of biotechnology. Cell cloning activities like mutagenesis and recombinant protein expression have been in focus since the outbreak of the pandemic, which in turn will positively influence the global competent cells market. In order to examine the SARSnCoV genome, there has been a high requirement for competent cells for the extraction of cloned copies of viral plasmids.

The growing investments from private and public companies along with the launch of novel products are likely to fuel the need for competent cells in the market globally. Biotechnology and genetic engineering have significantly expanded the scope of healthcare by facilitating treatment for a large number of diseases that were not initially feasible. However, the high demand for products extracted from recombinant DNA technology finds a large number of applications in therapeutic products like protein therapies and vaccines. These include various therapies ranging from human growth hormone to human insulin therapies.

Also, the presence of favorable reimbursement policies and an efficient regulatory landscape is likely to steer the growth of the global competent cells market significantly in the forthcoming years. However, the surging number of startups and small companies entering the market to explore the untapped potential of the global competent cells market will further boost market growth.

Global Competent Cells Market: Segmentation

The global competent cells market can be segmented into end-user, type, application, and region.

By End-user, the market can be segmented into contract research organizations, pharmaceutical & biotechnology companies, academic research institutes, and others. The pharmaceutical & biotechnology companies segment accounts for the largest share in the global competent cells market. The growth can be attributed to the growing research activities along with innovations and advancements in the field of proteomics and genomics-based products.

By Type, the market can be segmented into electro and chemically competent cells. The chemically competent cell segment dominates the global competent cells market. However, the electrocompetent cell segment is likely to grow with the highest CAGR due to the fact that it is suitable for a large number of molecular biology applications including the generation of cDNA libraries.

By Application, the market can be segmented into protein expression, cloning, and others. The cloning segment holds hegemony over others due to the ongoing research activities along with growing government funding support. The cloning segment can further be bifurcated into high-throughput cloning, unstable DNA cloning, phage display library construction, and subcloning & routine cloning. The other segment can further be bifurcated into a lentiviral vector, single-stranded DNA production, large plasma transformation, and mutagenesis.

Recent Development:

• In 2022, Thermo Fisher Scientific acquired a biotech firm specializing in competent cell technologies, strengthening its molecular biology portfolio.
• In February 2024, Bio-Rad Laboratories launched the Vericheck ddPCR Replication Competent Lentivirus Kit and AAV Kit, offering highly sensitive detection of viral contaminants to support the development of cell and gene therapies.
• In 2023, Merck KGaA introduced a new range of high-efficiency competent cells tailored for gene editing applications.
• In January 2024, SGI DNA released Vmax™ X2 Competent Cells, engineered to deliver 2–4 times more soluble protein in half the time compared to conventional E. coli cells.

Competent Cells Market : Report Scope

Competent Cells Market Dynamics:

key growth drivers

The competent cells market is primarily driven by the exponential growth in the fields of genetic engineering and molecular biology. Competent cells are a fundamental tool in these disciplines, essential for applications such as gene cloning, protein expression, and the development of recombinant DNA technology. The increasing focus on biopharmaceuticals and the rising global demand for vaccines and therapeutic proteins, fueled by the prevalence of chronic diseases and an aging population, are major market drivers. Additionally, growing investments in life sciences research and development by both public and and private sectors, along with the adoption of advanced techniques like CRISPR-Cas9 for gene editing, are propelling the demand for high-efficiency competent cells.

restraints

Despite strong growth, the competent cells market faces several restraints. A significant challenge is the high cost associated with the production and use of competent cells, particularly high-efficiency kits. This can be a barrier for smaller research laboratories and academic institutions with limited budgets. The market is also subject to consolidation, with a few large players dominating the landscape, which can create barriers to entry for new companies. Furthermore, the inherent technological limitations of some competent cells, such as their stability, sensitivity to handling, and the need for a strict cold chain for transportation and storage, can hinder their widespread adoption, particularly in emerging economies.

opportunities

The market is ripe with opportunities for innovation and growth. The emergence of novel therapeutics, particularly in gene and cell therapy, presents a significant avenue for expansion. Competent cells are critical for the development and production of these advanced therapies. The rapid expansion of synthetic biology and the development of biofoundries offer new applications for competent cells in high-throughput and automated workflows. The increasing trend of personalized medicine, which relies on understanding an individual's unique genetic makeup, also creates a demand for highly specialized and efficient competent cells. Furthermore, developing nations with expanding biotechnology sectors, such as those in the Asia-Pacific region, offer significant untapped market potential.

challenges

The competent cells market is confronted with several challenges. The most pressing challenge is the intense competition and the need for continuous technological advancement to maintain a competitive edge. Companies must constantly innovate to improve transformation efficiency and develop new strains of competent cells to meet evolving research needs. The lack of standardized protocols and the need for specialized technical expertise for certain applications can also pose a challenge for end-users. Additionally, ethical concerns surrounding the use of genetically modified organisms and stringent regulatory frameworks can add complexity and cost to the development and commercialization of these products. Supply chain disruptions and the fragility of the products themselves also present logistical hurdles.

Global Competent Cells Market: Regional analysis

North America accounts for the largest share in the global competent cells market due to the several research activities happening in the field of recombinant protein and cloning technology. Also, the presence of key market leaders in the field of competent cells in the region is likely to further accentuate the growth of the regional market. The presence of favorable reimbursement and medical policies in the region will also encourage the development and innovation in the field of biotechnology using competent cells.

Global Competent Cells Market: Competitive Players

The global competent cells market is led by players like:

• Origene Technologies Inc
• Genscript
• Qiagen
• Illumina, Inc
• Agilent Technologies
• Bio-Rad Laboratories Inc
• New England Biolabs
• Takara Bio, Inc
• Promega Corporation
• Merck KGaA

The global competent cells market is segmented as follows:

By Type

• Electro
• Chemically Competent Cells

By Application

• Protein Expression
• Cloning
• Others

By End User

• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Others

Global Competent Cells Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.